DK1743027T3 - Mutantpneumolysinproteiner - Google Patents

Mutantpneumolysinproteiner

Info

Publication number: DK1743027T3
Authority: DK; Denmark
Prior art keywords: mutant pneumolysin; pneumolysin proteins; proteins; mutant; pneumolysin
Prior art date: 2004-05-07

Application number

DK05742528.2T

Other languages

English (en)

Inventor

Lea-Ann Kirkham

Timothy John Mitchell

Original Assignee

Univ Glasgow

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-07

Filing date

2005-05-09

Publication date

2013-09-30

2005-05-09 Application filed by Univ Glasgow filed Critical Univ Glasgow

2013-09-30 Application granted granted Critical

2013-09-30 Publication of DK1743027T3 publication Critical patent/DK1743027T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Gram-positive bacteria
- C07K16/1275—Streptococcus (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Oncology (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK05742528.2T 2004-05-07 2005-05-09 Mutantpneumolysinproteiner DK1743027T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US56941504P	2004-05-07	2004-05-07
GBGB0410220.8A GB0410220D0 (en)	2004-05-07	2004-05-07	Mutant pneumolysin proteins
PCT/GB2005/001792 WO2005108580A1 (en)	2004-05-07	2005-05-09	Mutant pneumolysin proteins

Publications (1)

Publication Number	Publication Date
DK1743027T3 true DK1743027T3 (da)	2013-09-30

Family

ID=32482854

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05742528.2T DK1743027T3 (da)	2004-05-07	2005-05-09	Mutantpneumolysinproteiner

Country Status (15)

Country	Link
US (1)	US7820789B2 (da)
EP (1)	EP1743027B1 (da)
JP (1)	JP4848552B2 (da)
KR (1)	KR101191591B1 (da)
CN (1)	CN101018863B (da)
AU (1)	AU2005240835B2 (da)
CA (1)	CA2566344C (da)
DK (1)	DK1743027T3 (da)
ES (1)	ES2427978T3 (da)
GB (1)	GB0410220D0 (da)
IL (2)	IL178885A (da)
PL (1)	PL1743027T3 (da)
PT (1)	PT1743027E (da)
SI (1)	SI1743027T1 (da)
WO (1)	WO2005108580A1 (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX339524B (es)	2001-10-11	2016-05-30	Wyeth Corp	Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
US7785608B2 (en)	2002-08-30	2010-08-31	Wyeth Holdings Corporation	Immunogenic compositions for the prevention and treatment of meningococcal disease
WO2007144647A2 (en) *	2006-06-15	2007-12-21	Timothy John Mitchell	Adjuvant compositions
AR064642A1 (es)	2006-12-22	2009-04-15	Wyeth Corp	Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
AU2008287286B2 (en) *	2007-04-13	2013-10-10	The Board Of Regents Of The University Of Oklahoma	Mutants of cholesterol-dependent cytolysins and uses thereof
GB0714963D0 (en)	2007-08-01	2007-09-12	Novartis Ag	Compositions comprising antigens
NZ586430A (en) *	2007-12-21	2012-09-28	Novartis Ag	Mutant forms of streptolysin o (slo)
EP2293815A4 (en) *	2008-05-22	2013-04-03	Childrens Medical Center	SYNERGISTIC IMMUNOGENIC FUSION PROTEIN POLYSACCHARIDE CONJUGATE
CN106008679A (zh) *	2008-12-24	2016-10-12	荷兰王国卫生福利和运动部国家公共卫生和环境研究所	修饰的肺炎链球菌溶血素(ply)多肽
EP3017826A1 (en)	2009-03-24	2016-05-11	Novartis AG	Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
DK2424562T3 (da) *	2009-04-30	2015-12-07	Coley Pharm Group Inc	Pneumokokvaccine og anvendelser deraf
CN102695523A (zh)	2009-09-10	2012-09-26	诺华有限公司	针对呼吸道疾病的组合疫苗
KR20120107121A (ko) *	2009-12-22	2012-09-28	사노피 파스퇴르 리미티드	면역원성 조성물
WO2011075822A1 (en) *	2009-12-22	2011-06-30	Sanofi Pasteur Limited	Immunogenic compositions and related methods
CA2808975C (en)	2010-08-23	2018-10-30	Wyeth Llc	Stable formulations of neisseria meningitidis rlp2086 antigens
KR101584871B1 (ko)	2010-09-10	2016-01-22	와이어쓰 엘엘씨	네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체
WO2012072769A1 (en)	2010-12-01	2012-06-07	Novartis Ag	Pneumococcal rrgb epitopes and clade combinations
US9181308B2 (en)	2011-03-28	2015-11-10	St. Jude Children's Research Hospital	Methods and compositions employing immunogenic fusion proteins
EP2694667B1 (en)	2011-04-08	2016-12-07	Baystate Medical Center, Inc.	Methods, compositions and kits for assaying mitochondrial function
MX383544B (es) *	2011-04-21	2025-03-14	Univ Rockefeller	Lisinas de bacteriofago de streptococcus para la deteccion y tratamiento de bacterias gram positivas
RU2632651C2 (ru)	2011-05-11	2017-10-06	Чилдрен'С Медикал Сентер Корпорейшн	Модифицированный биотин-связывающий белок, слитые белки на его основе и их применение
KR20140033127A (ko)	2011-05-17	2014-03-17	글락소스미스클라인 바이오로지칼즈 에스.에이.	스트렙토코쿠스 뉴모니애에 대한 백신
ITMI20111182A1 (it)	2011-06-28	2012-12-29	Canio Buonavoglia	Vaccino per coronavirus canino
WO2013131983A1 (en)	2012-03-07	2013-09-12	Novartis Ag	Adjuvanted formulations of streptococcus pneumoniae antigens
CA2865745C (en)	2012-03-09	2018-01-09	Pfizer Inc.	Neisseria meningitidis compositions and methods thereof
SA115360586B1 (ar)	2012-03-09	2017-04-12	فايزر انك	تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
EP4272750A3 (en)	2013-02-07	2024-01-24	Children's Medical Center, Corp.	Protein antigens that provide protection against pneumococcal colonization and/or disease
CA2903716C (en)	2013-03-08	2019-04-09	Pfizer Inc.	Immunogenic fusion polypeptides
US11207396B2 (en)	2013-05-17	2021-12-28	The Board Of Regents Of The University Of Texas System	Immunization to protect against adverse cardiac events relating to pneumococcal infection
RU2662968C2 (ru)	2013-09-08	2018-07-31	Пфайзер Инк.	Иммуногенная композиция против neisseria meningitidis (варианты)
CN103936842B (zh) *	2014-04-30	2016-03-23	重庆医科大学	肺炎链球菌溶血素突变体及其作为粘膜免疫佐剂的应用
US9107906B1 (en)	2014-10-28	2015-08-18	Adma Biologics, Inc.	Compositions and methods for the treatment of immunodeficiency
ES2993430T3 (en) *	2014-11-21	2024-12-30	Univ Oklahoma	Pneumolysin mutants and methods of use thereof
KR20190049940A (ko)	2015-02-19	2019-05-09	화이자 인코포레이티드	나이세리아 메닌지티디스 조성물 및 그의 방법
GB201610599D0 (en)	2016-06-17	2016-08-03	Glaxosmithkline Biologicals Sa	Immunogenic Composition
SG11201906519RA (en)	2017-01-31	2019-08-27	Pfizer	Neisseria meningitidis compositions and methods thereof
US10259865B2 (en)	2017-03-15	2019-04-16	Adma Biologics, Inc.	Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
EP3600400A4 (en)	2017-03-28	2021-01-13	The Children's Medical Center Corporation	MULTIPLE ANTIGEN (MAPS) BASED STAPHYLOCOCCUS AUREUS VACCINE, IMMUNOGENIC COMPOSITION AND USES THEREOF
SG11201912601RA (en)	2017-06-23	2020-01-30	Nosocomial Vaccine Corp	Immunogenic compositions
CN113164580B (zh)	2018-09-12	2025-06-10	儿童医疗中心公司	肺炎球菌融合蛋白疫苗
CN112969474A (zh)	2018-09-12	2021-06-15	艾芬尼维克斯公司	多价肺炎球菌疫苗
CA3155669A1 (en)	2019-09-27	2021-04-01	Pfizer Inc.	Neisseria meningitidis compositions and methods thereof
WO2022199527A1 (zh) *	2021-03-22	2022-09-29	星济生物(苏州)有限公司	靶向肺炎链球菌溶血素的抗原结合蛋白及其用途
CN113264999B (zh) *	2021-04-29	2023-02-28	星济生物(苏州)有限公司	中和肺炎链球菌溶血素蛋白的抗原结合蛋白及其用途
MX2024002779A (es)	2021-09-09	2024-06-11	Affinivax Inc	Vacunas neumocócicas multivalentes.
EP4433080A1 (en)	2021-11-18	2024-09-25	Matrivax, Inc.	Immunogenic fusion protein compositions and methods of use thereof
WO2025193903A1 (en)	2024-03-15	2025-09-18	Affinivax, Inc.	Pneumococcal polysaccharide compositions and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5078996A (en)	1985-08-16	1992-01-07	Immunex Corporation	Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US4912094B1 (en)	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
US6716432B1 (en) *	1988-12-16	2004-04-06	James Cleland Paton	Pneumolysin mutants and pneumococcal vaccines made therefrom
JP3237842B2 (ja) *	1988-12-16	2001-12-10	オランダ国	ニューモリシンミュータント及びそれから製造されたニューモコッカルワクチン
IL101715A (en)	1991-05-02	2005-06-19	Amgen Inc	Recombinant dna-derived cholera toxin subunit analogs
WO1993013302A1 (de)	1991-12-23	1993-07-08	Michael Zoche	Motor mit einer vorrichtung zur entölung
US6207646B1 (en)	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US5565204A (en) *	1994-08-24	1996-10-15	American Cyanamid Company	Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
CA2745736C (en)	1996-10-23	2016-11-22	The Trustees Of The University Of Pennsylvania	Immunotherapy and improved vaccines
US6113918A (en)	1997-05-08	2000-09-05	Ribi Immunochem Research, Inc.	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
AU740956B2 (en) *	1997-07-21	2001-11-15	Baxter Healthcare Sa	Modified immunogenic pneumolysin compositions as vaccines
TWI239847B (en)	1997-12-02	2005-09-21	Elan Pharm Inc	N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7964192B1 (en)	1997-12-02	2011-06-21	Janssen Alzheimer Immunotherapy	Prevention and treatment of amyloidgenic disease
WO1999043839A1 (en)	1998-02-27	1999-09-02	The Trustees Of The University Of Pennsylvania	Vaccines, immunotherapeutics and methods for using the same
JP4673974B2 (ja)	1998-09-30	2011-04-20	ワイス・ホールディングズ・コーポレイション	アジュバントとしての変異コレラホロトキシン
US7332174B2 (en)	2001-06-07	2008-02-19	Wyeth Holdings Corporation	Mutant forms of cholera holotoxin as an adjuvant
WO2002098368A2 (en)	2001-06-07	2002-12-12	Wyeth Holdings Corporation	Mutant forms of cholera holotoxin as an adjuvant
SG149013A1 (en)	2003-12-17	2009-01-29	Wyeth Corp	Immunogenic peptide carrier conjugates and methods of producing same

2004
- 2004-05-07 GB GBGB0410220.8A patent/GB0410220D0/en not_active Ceased
2005
- 2005-05-09 SI SI200531774T patent/SI1743027T1/sl unknown
- 2005-05-09 ES ES05742528T patent/ES2427978T3/es not_active Expired - Lifetime
- 2005-05-09 US US11/568,802 patent/US7820789B2/en not_active Expired - Fee Related
- 2005-05-09 CN CN2005800220763A patent/CN101018863B/zh not_active Expired - Fee Related
- 2005-05-09 AU AU2005240835A patent/AU2005240835B2/en not_active Ceased
- 2005-05-09 JP JP2007512334A patent/JP4848552B2/ja not_active Expired - Fee Related
- 2005-05-09 KR KR1020067025760A patent/KR101191591B1/ko not_active Expired - Fee Related
- 2005-05-09 PT PT57425282T patent/PT1743027E/pt unknown
- 2005-05-09 DK DK05742528.2T patent/DK1743027T3/da active
- 2005-05-09 WO PCT/GB2005/001792 patent/WO2005108580A1/en not_active Ceased
- 2005-05-09 EP EP05742528.2A patent/EP1743027B1/en not_active Expired - Lifetime
- 2005-05-09 CA CA2566344A patent/CA2566344C/en not_active Expired - Fee Related
- 2005-05-09 PL PL05742528T patent/PL1743027T3/pl unknown
2006
- 2006-10-26 IL IL178885A patent/IL178885A/en not_active IP Right Cessation
2010
- 2010-01-24 IL IL203479A patent/IL203479A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR101191591B1 (ko)	2012-10-15
IL178885A0 (en)	2007-03-08
CA2566344C (en)	2015-07-07
CN101018863A (zh)	2007-08-15
ES2427978T3 (es)	2013-11-05
KR20070073602A (ko)	2007-07-10
IL203479A (en)	2013-04-30
AU2005240835A1 (en)	2005-11-17
EP1743027B1 (en)	2013-07-10
GB0410220D0 (en)	2004-06-09
PT1743027E (pt)	2013-10-08
PL1743027T3 (pl)	2013-11-29
SI1743027T1 (sl)	2013-10-30
CA2566344A1 (en)	2005-11-17
JP2008505617A (ja)	2008-02-28
US20080112964A1 (en)	2008-05-15
EP1743027A1 (en)	2007-01-17
IL178885A (en)	2011-11-30
JP4848552B2 (ja)	2011-12-28
WO2005108580A1 (en)	2005-11-17
AU2005240835B2 (en)	2011-12-01
US7820789B2 (en)	2010-10-26
CN101018863B (zh)	2012-01-04

Publication	Publication Date	Title
GB0410220D0 (en)	2004-06-09	Mutant pneumolysin proteins
DE50310628D1 (de)	2008-11-20	Erfahren
DK1699821T3 (da)	2012-07-16	Fc-ERYTHROPOIETIN-FUSIONSPROTEIN MED FORBEDREDE FARMAKOKINETIKKER
DE602005025468D1 (de)	2011-02-03	Gssystem
DE602005021602D1 (de)	2010-07-15	Neigungsverstellvorrichtung
ITMI20041571A1 (it)	2004-10-30	Perfluoroelastomeri
DK1804871T3 (da)	2012-10-01	Forbedret mellemstykke
DE602005023894D1 (de)	2010-11-11	Rücklehnvorrichtung
DK1809660T3 (da)	2014-10-20	Thymus-specifikt protein
GB0423974D0 (en)	2004-12-01	Proteins
ATE521769T1 (de)	2011-09-15	Beschlag
DE60322439D1 (de)	2008-09-04	Anschlussstück
ES1064684Y (es)	2007-07-16	Tapizado
DE502004000407D1 (de)	2006-05-18	Sitzmöbel
GB0423002D0 (en)	2004-11-17	Proteins
NO20040521A (no)	2005-06-13	Proteinutskiller
GB0401882D0 (en)	2004-03-03	Protein
SE0400209D0 (sv)	2004-02-02	Novel methods
ES1060725Y (es)	2006-02-16	Reclinalibros
ES1057547Y (es)	2004-12-01	Roldana mejorada
UA10445S (uk)	2005-07-15	Подушка
ES1057042Y (es)	2004-10-01	Conjunto anillo-pendientes
SE0400497D0 (sv)	2004-03-02	Artikulator
GB0411678D0 (en)	2004-06-30	Proteins
GB0415161D0 (en)	2004-08-11	Proteins